Pacific Edge Of New Zealand Seeks More Shareholder Funds
This article was originally published in PharmAsia News
Executive Summary
New Zealand's Pacific Edge Biotechnology is reaching back to its current shareholders to come up with more funds to help the firm get its bladder-cancer test to market